OLMA · Olema Pharmaceuticals, Inc.
$11.58
-0.18 (-1.53%)
At close · Aug 5
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have incurred net losses since inception, and we expect to continue to incur net losses for the foreseeable future. In addition, we may be unable to continue as a going concern over the long term.”View the 10-Q filed May 12, 2026
Market Cap
$985.28M
Shares
87.35M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-23 | 2026-06-17 | |
| 8-K | 2026-05-26 | — | |
| 8-K | 2026-05-21 | — | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-01 | 2026-04-27 | |
| DEF 14A | 2026-04-29 | — | |
| 8-K | 2026-04-29 | 2026-04-27 | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-01-30 | 2026-01-27 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-19 | — | |
| 8-K | 2025-11-18 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-10-20 | 2025-10-18 | |
| 8-K | 2025-09-02 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-06-13 | 2025-06-10 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-28 | — | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-03-05 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-10 | 2024-12-09 | |
| 8-K | 2024-12-02 | 2024-11-29 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-09-27 | — | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-07-02 | 2024-06-28 | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-05-15 | — | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2023-12-31 | |
| 10-K | 2024-03-11 | 2023-12-31 | |
| 8-K | 2024-03-11 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-05 | — | |
| 8-K | 2023-12-06 | — |
Showing 1–50 of 93 filings
Key facts
CIK
1750284
CUSIP
68062P106
13F (30d)
31 filings
31 filers
Visit website
Investor relations